Sign up for the QMED & MD+DI Daily newsletter.
AdvaMed Praises New Version of Disclosure Bill
AdvaMed said it supports the changes recently made to a Senate bill on disclosure to patients of doctors' financial ties to drug and device companies. "This bill is an important step forward in improving transparency and does so in a manner that does not jeopardize future innovation. Thatâ€™s good news for patients, physicians and industry," said Stephen J.
May 22, 2008
1 Min Read
Ubl, president and CEO of AdvaMed.The modifications include preemption of state disclosure laws to ensure consistency; requiring compliance by physician-owned manufacturers, distributors, and group purchasing organizations; and requiring disclosure information to be displayed in an easy-to-understand manner. AdvaMed would like to see one more change: exempting companies who pay less than $250,000 per year to physicians.
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read